IP Verse

Polymorphs Of 2'-O-Fucosyllactose And Producing Thereof - EP2576578

The patent EP2576578 was granted to Glycom on Sep 19, 2018. The application was originally filed on Jun 1, 2011 under application number EP11789282A. The patent is currently recorded with a legal status of "Revoked".

EP2576578

GLYCOM
Application Number
EP11789282A
Filing Date
Jun 1, 2011
Status
Revoked
Jan 19, 2024
Grant Date
Sep 19, 2018
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

BASFJun 19, 2019 -

Patent Citations (13) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONWO2010115934
DESCRIPTIONWO2010115935
EXAMINATIONWO2014009921
INTERNATIONAL-SEARCH-REPORTWO2010070616
INTERNATIONAL-SEARCH-REPORTWO2010115934
OPPOSITIONEP1332759
OPPOSITIONEP2072052
OPPOSITIONWO2010070616
OPPOSITIONWO2010115934
OPPOSITIONWO2011005681
OPPOSITIONWO2011150939
OPPOSITIONWO2014009921
SEARCHWO9843494

Non-Patent Literature (NPL) Citations (14) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
DESCRIPTION- KUHN ET AL., CHEM. BER., (1955), vol. 88, page 1135-
EXAMINATION- Harry Brittain ET AL, "Polymorphism in pharmaceutical solids", Polymorphism in Pharmaceutical solids, NEW YORK * BASEL, ISBN 978-0-8247-0237-3, (19990101), URL: http://www.ivtnetwork.com/sites/default/files/Amorphous_01.pdf, XP055339290-
EXAMINATION- CAIRA, "Crystalline Polymorphism of Organic Compounds", TOPICS IN CURRENT CHEMISTRY, SPRINGER, BERLIN, DE, (19980101), vol. 198, ISSN 0340-1022, pages 163 - 208, XP008166276
INTERNATIONAL-SEARCH-REPORT- ABBAS, S. A. ET AL., "Synthesis of O-a-L-Fucopyranosyl-(1-2) -O-b-D-Galactopyranosyl-( -4)-D-Glucopyranose (2'-O-a-L-Fucopyranosyl-lactose)", CARBOHYDR. RES., (1981), vol. 88, no. 1, pages 51 - 60, XP026743786-
INTERNATIONAL-SEARCH-REPORT- KUHN, R. ET AL., "Fucosido-lactose, das Trisaccharid der Frauenmilch", CHEM. BER., (1955), vol. 88, no. 8, pages 1135 - 1146, XP009074771-
INTERNATIONAL-SEARCH-REPORT- KUHN, R. ET AL., "Kristalliserte Fucosido-lactose", CHEM. BER., (1956), vol. 89, no. 11, page 2513, XP009074773-
INTERNATIONAL-SEARCH-REPORT- FERNANDEZ-MAYORALES, A. ET AL., "Synthesis of 3- and 2'-fucosyl-lactose and 3,2'-difucosyl-lactose from partially benzylated lactose derivatives", CARBOHYDR. RES., (1986), vol. 154, no. 1, pages 93 - 101, XP026618813
OPPOSITION- Anonymous, "2'-Fucosyllactose, Wikipedia the free encyclopedia", (20180926), pages 1 - 2, URL: https://en.wikipedia.org/w/index.php?title=2'-Fucosyllactose&oldid=861272154, XP055619109-
OPPOSITION- BAVIN, M., "Polymorphism in Process Development", Chemistry & Industry, (19890821), pages 527 - 529, XP001180136-
OPPOSITION- KUHN, R. et al., "Kristallisierte Fucosido-lactose", Chemische Berichte, (19560000), vol. 89, no. 11, page 2513, XP009074773-
OPPOSITION- RUDOLPH, MACY, "The history of a melting point", Chem. Educ., (19470000), vol. 24, no. 5, page 22, XP055619114-
OPPOSITION- ABBAS, S. et al., "Synthesis of O-alpha-L-fucopyranosyl-(1-2)-O-beta-D-galactopyranosyl-(1-4)-D-glucopyranose (2'-O-alpha-L-fucopyranosyl-lactose)", CARBOHYDRATE RESEARCH, (19810000), vol. 88, no. 1, pages 51 - 60, XP002545671
OPPOSITION- BYRN, S. et al., "Pharmaceutical Solids: A strategic Approach to Regulatory Considerations", Pharmaceutical Research, (19950700), vol. 12, no. 7, pages 945 - 954, XP000996386
SEARCH- MASAYUKI IZUMI ET AL, "-Fucosidases +", THE JOURNAL OF ORGANIC CHEMISTRY, (19970201), vol. 62, no. 4, doi:10.1021/jo961725h, ISSN 0022-3263, pages 992 - 998, XP055085232 [I] 1-15 * synthesis of compound 34; enzyme inhibition assays;; example - * * example - *

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents